Nuclera is a venture-backed, founder-driven biotech company headquartered in Cambridge, UK with significant operations in Boston, USA. Our purpose is to improve human health by making proteins accessible to life science researchers around the world.
In 2024, we launched eProtein Discovery™ - a breakthrough protein expression, characterization, and purification platform, consisting of cloud-based software and a lab-based instrument (with proprietary cartridges and consumables). Since then, we have established a growing installed base in North America, Europe and Asia, receiving numerous awards and customer accolades.
We are looking for an experienced full-stack software engineer to work on our customer-facing cloud and instrument software as well as the internal tools that support our in-house protein screening services. You’ll be involved in the full software development lifecycle, including working closely with biologists and other stakeholders to define use-cases and requirements, translating those requirements into technical designs, implementing those designs in code and writing tests to verify its correctness. No prior knowledge of biology is necessary, but curiosity and an eagerness to learn is critical.
This role is for you if you:
In addition to competitive salaries, we offer a range of benefits including:
Nuclera exists to remove uncertainty from protein science. As the pioneer of multiplex protein screening, we help researchers start with clarity, so ideas move faster to result. We believe access to your protein should be a certainty, not a gamble. eProtein Discovery™ is how we deliver on that promise, but our aim is bigger: to make protein access routine for every lab, accelerate breakthroughs in human health, and empower scientists to spend more time on discovery and less on delay.
Our eProtein Discovery™ system combines unique cell free expression systems, novel digital microfluidics, and robust screening data, to create an effortlessly multiplex protein screening solution that empowers you to perform your own protein screening, characterization, and small-scale expression in-house within days — even challenging membrane proteins
Founded in 2013 by PhD students at the University of Cambridge, the company now has a presence in Cambridge, UK and Boston, MA employing over 100 employees.
